N4 Pharma Plc
LSE: N4P.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Horn Solomon
- Employees
- 5
- Headquarters
- London, United Kingdom
- IPO year
- 1988
- Market cap
- £4.0M
- Website
- https://www.n4pharma.com
Loading N4P…
Loading profile data…Frequently asked questions about N4P
What does N4 Pharma Plc (N4P.L) do?
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Where does N4P.L trade?
N4 Pharma Plc (N4P.L) trades on the London Stock Exchange.
What sector is N4P.L in?
N4 Pharma Plc (N4P.L) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of N4 Pharma Plc?
David Horn Solomon is the chief executive officer of N4 Pharma Plc (N4P.L).
Where is N4 Pharma Plc headquartered?
N4 Pharma Plc is headquartered in United Kingdom.
Does N4P.L pay a dividend?
N4 Pharma Plc (N4P.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did N4P.L go public?
N4 Pharma Plc (N4P.L) completed its initial public offering in 1988.